Duration of androgen suppression in prostate cancer

N Engl J Med. 2009 Sep 17;361(12):1212; author reply 1212-3. doi: 10.1056/NEJMc091433.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Humans
  • Male
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / radiotherapy

Substances

  • Androgen Antagonists
  • Prostate-Specific Antigen